Venus Remedies shares slump 20% after Crisil downgrade

Image
Press Trust of India Mumbai
Last Updated : Sep 16 2014 | 5:15 PM IST
Shares of Venus Remedies slumped 20 per cent today after ratings agency Crisil downgraded its ratings on the company's bank facilities.
Following this, Venus Remedies' scrip tumbled 20 per cent to settle at Rs 302.80 on the BSE.
At the NSE, the stock plunged 19.99 per cent to close at Rs 302.10.
Led by the dip in the stock, the company's market value fell by Rs 86.54 crore to Rs 346.46 crore.
On the volume front, 10.80 lakh shares of the company changed hands at the BSE, while over 31 lakh shares were traded at the NSE during the day.
Crisil has downgraded its ratings on the bank facilities of Venus Remedies to Crisil D/Crisil D' from 'Crisil BB+/Stable/Crisil A4+'.
The rating downgrade reflects delays in repayment of term loan by the company driven by a stretched liquidity, the rating agency said.
VRL's stretched liquidity is on account of the significant increase in total cost of the large debt-funded capital expenditure over the past one year and high working capital requirements, CRISL said in a report issued yesterday.
The company is undertaking capex towards setting up marketing office. The total cost of this capex is estimated to have increased by about Rs 100 to 150 million. In addition to the above company's liquidity has also deteriorated on account of the high working capital requirements reflected by inventory of about 131 days as on March 31, 2014.
The ratings continue to reflect VRL's comfortable financial risk profile, marked by a healthy net worth and strong debt protection metrics.
The ratings also factor in the company's strong presence in the high-value critical care segment and the healthy growth in its domestic and export sales.
For arriving at the ratings, Crisil has combined the business and financial risk profiles of VRL and its wholly owned subsidiary, Venus Pharma GmbH (VP), based in Germany. VP provides out-licensing services of common technical documents, and warehousing and logistical support to VRL. The two entities have together been referred to as VRL, Crisil added.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 16 2014 | 5:15 PM IST

Next Story